• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃神经内分泌肿瘤的分类及其与生存的关联。

Classification of Gastric Neuroendocrine Tumors and Associations With Survival.

作者信息

Song Yun, Chen Eunise, Chiang Yi-Ju, Yao James C, Halperin Daniel M, Chatterjee Deyali, Badgwell Brian D

机构信息

Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Department of Surgery, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

出版信息

J Surg Oncol. 2025 Feb;131(2):204-211. doi: 10.1002/jso.27876. Epub 2024 Sep 10.

DOI:10.1002/jso.27876
PMID:39257200
Abstract

BACKGROUND AND OBJECTIVES

Not all gastric neuroendocrine tumors (GNETs) may be classified into one of the three described clinicopathologic subtypes. The purpose of this study was to better characterize GNET subtypes and associated outcomes.

METHODS

Patients treated for GNET at our institution (1995-2021) were identified. Pathologic specimens of tumors that could not be classified as type 1, 2, or 3 were further reviewed. GNETs were categorized as proton pump inhibitor (PPI)-associated based on changes in the background gastric mucosa consistent with PPI use. Distant metastasis at presentation (DM) and disease-specific survival (DSS) were evaluated.

RESULTS

Among 246 patients, there were 164 (67%) type 1, 5 (2%) type 2, 52 (21%) type 3, and 18 (7%) PPI-associated GNETs. Seven (3%) tumors remained unclassified. DM was more frequent with type 3 GNETs (38%) than type 1 (1%), type 2 (20%), or PPI-associated tumors (11%, p < 0.001). Ten-year DSS rates were 100% for type 1, 53% (95% confidence interval [CI], 38%-75%) for type 3, and 80% (95% CI, 58%-100%) for PPI-associated tumors (p < 0.001). GNET subtype, race, and DM were independently associated with DSS.

CONCLUSIONS

PPI-associated tumors may represent a distinct GNET subtype with intermediate outcomes. Other factors should also be considered in overall prognosis.

摘要

背景与目的

并非所有胃神经内分泌肿瘤(GNETs)都可归类为已描述的三种临床病理亚型之一。本研究的目的是更好地描述GNET亚型及其相关预后。

方法

确定在我们机构(1995 - 2021年)接受GNET治疗的患者。对无法分类为1型、2型或3型的肿瘤病理标本进行进一步复查。根据与质子泵抑制剂(PPI)使用一致的背景胃黏膜变化,将GNETs归类为PPI相关型。评估就诊时的远处转移(DM)和疾病特异性生存(DSS)情况。

结果

246例患者中,有164例(67%)为1型,5例(2%)为2型,52例(21%)为3型,18例(7%)为PPI相关型GNETs。7例(3%)肿瘤仍未分类。3型GNETs的DM发生率(38%)高于1型(1%)、2型(20%)或PPI相关型肿瘤(11%,p < 0.001)。1型的10年DSS率为100%,3型为53%(95%置信区间[CI],38% - 75%),PPI相关型肿瘤为80%(95% CI,58% - 100%)(p < 0.001)。GNET亚型、种族和DM与DSS独立相关。

结论

PPI相关型肿瘤可能代表一种具有中等预后的独特GNET亚型。在总体预后中还应考虑其他因素。

相似文献

1
Classification of Gastric Neuroendocrine Tumors and Associations With Survival.胃神经内分泌肿瘤的分类及其与生存的关联。
J Surg Oncol. 2025 Feb;131(2):204-211. doi: 10.1002/jso.27876. Epub 2024 Sep 10.
2
Gastric NET Subtypes: Do We Need An Additional One?胃神经内分泌肿瘤亚型:我们是否还需要另一个?
Z Gastroenterol. 2021 Mar;59(3):255-258. doi: 10.1055/a-1348-2727. Epub 2021 Jan 27.
3
Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.长期使用质子泵抑制剂的患者发生的胃神经内分泌肿瘤为惰性肿瘤,预后良好。
Histopathology. 2020 Dec;77(6):865-876. doi: 10.1111/his.14220. Epub 2020 Sep 20.
4
Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use.肠嗜铬样细胞增生相关胃神经内分泌肿瘤可能与质子泵抑制剂的使用有关。
Arch Pathol Lab Med. 2022 Mar 1;146(3):366-371. doi: 10.5858/arpa.2020-0315-OA.
5
A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?胃神经内分泌肿瘤15年的经验:类型有影响吗?
J Surg Oncol. 2016 Oct;114(5):576-580. doi: 10.1002/jso.24369. Epub 2016 Jul 8.
6
Clinical Characteristics and Long-term Outcomes of Gastric Neuroendocrine Tumors.胃神经内分泌肿瘤的临床特征与长期预后
Gut Liver. 2025 Mar 15;19(2):189-197. doi: 10.5009/gnl240272. Epub 2025 Jan 3.
7
Defining prognostic parameters of well-differentiated gastric neuroendocrine tumors based on metastatic potential: a two-center experience.基于转移潜能定义胃神经内分泌肿瘤分化良好的预后参数:一项两中心经验。
Acta Gastroenterol Belg. 2022 Apr-Jun;85(2):339-345. doi: 10.51821/85.2.8601.
8
The Morphologic Spectrum of Gastric Type 1 Enterochromaffin-Like Cell Neuroendocrine Tumors.胃 1 型嗜铬素 A 样细胞神经内分泌肿瘤的形态学谱系。
Mod Pathol. 2023 Apr;36(4):100098. doi: 10.1016/j.modpat.2023.100098. Epub 2023 Jan 10.
9
Gastric Neuroendocrine Tumors: Reappraisal of Type in Predicting Outcome.胃神经内分泌肿瘤:对预测预后类型的重新评估。
Ann Surg Oncol. 2021 Dec;28(13):8838-8846. doi: 10.1245/s10434-021-10293-7. Epub 2021 Jun 13.
10
Serum Gastrin Levels Are Associated With Prevalent Neuroendocrine Tumors in Autoimmune Metaplastic Atrophic Gastritis.血清胃泌素水平与自身免疫性化生萎缩性胃炎中神经内分泌肿瘤的患病率相关。
Am J Gastroenterol. 2025 May 1;120(5):1140-1143. doi: 10.14309/ajg.0000000000003235. Epub 2024 Nov 26.

引用本文的文献

1
Gastrointestinal Neuroectodermal Tumor/Extraskeletal Ewing Sarcoma of the Ileum with Ulcerative Colitis.回肠胃肠道神经外胚层肿瘤/骨外尤文肉瘤合并溃疡性结肠炎
Case Rep Gastroenterol. 2024 Dec 12;18(1):449-453. doi: 10.1159/000542659. eCollection 2024 Jan-Dec.